ReadyRx Review
Best for: LegitScript-certified compounded GLP-1 with batch lab testing under $200
ReadyRx (readyrx.com) is a LegitScript-certified US telehealth provider offering compounded semaglutide from $179/mo and compounded tirzepatide from $255/mo, plus NAD+, sermorelin, glutathione, MIC+B12, and metformin. Marketed as serving 5,000+ members across all 50 states with batch lab testing for potency, sterility, pH, and endotoxicity.
What the monthly price covers
Medication
Not disclosed
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
ReadyRx is a solid telehealth option with balanced features and pricing.
ReadyRx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $179/mo
- What's included
- Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored ReadyRx
Each dimension is scored algorithmically from ReadyRx’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.7/10At $179/mo, ReadyRx runs about 6% above the $170 median for GLP-1 providers.
Effectiveness25%
8.0/10ReadyRx offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.2/10Online intake and platform experience — consult included in the price; 6 platform features disclosed.
Trust & Safety15%
7.2/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-05).
Accessibility10%
8.1/10ReadyRx treats patients in all 50 states.
Support10%
5.7/10ReadyRx provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this ReadyRx review
Last checked 2026-06-05- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications ReadyRx offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Peptides ReadyRx offers
Beyond GLP-1s, ReadyRx also offers these peptides — tap any for our evidence-based guide.
Pricing
Ready to get started?
Plans and promotions change often — check ReadyRx's current pricing and active discounts before you decide.
What we like
- LegitScript Certified — verifiable via the badge link in the footer
- Batch lab testing covers the right QA metrics for injectables: potency, sterility, pH, and endotoxicity
- Pricing shown publicly: $179/mo semaglutide, $255/mo tirzepatide
Watch-outs
- Pharmacy partners not named — only described as 'FDA-registered compounding pharmacies'
- Clinicians described as licensed and board-certified, but no names or credentials published
- 5,000+ member figure comes from a directory listing, not an independent audit
ReadyRx in one line: a budget compounded GLP-1 program that shows its homework on quality
ReadyRx is a US telehealth service built around one straightforward pitch: get compounded semaglutide or tirzepatide at a low monthly price, from a company that can actually point to its safety paperwork. Compounded semaglutide starts at $179 a month, which lands below our category median of $170. For people who have priced out brand-name Wegovy or Zepbound and walked away because the list price runs well over a thousand dollars a month, ReadyRx is squarely aimed at you. It is not a luxury, white-glove concierge service — it's a value play that leans hard on two trust signals most cheap compounders skip: LegitScript certification and published batch lab testing.
How the pricing actually works (read the fine print on the quarterly plan)
The headline $179 for semaglutide is real, but there's a catch worth understanding before you sign up. ReadyRx's pricing cards display rates that apply to quarterly plans paid up front — in other words, the most attractive number assumes you commit to and pay for three months at once, not a casual month-to-month trial. Tirzepatide, the stronger dual-action molecule, starts higher, in the mid-two-hundreds a month on the same structure. The consult is bundled into the program, so you are not nickel-and-dimed with a separate doctor's visit fee, and shipping is free and discreet. That bundling matters: a price that looks low can quietly balloon once a competitor tacks on a membership charge or a per-visit fee, and ReadyRx avoids that particular trap.
- Compounded semaglutide: from $179/mo, lower than the $170 category median
- Compounded tirzepatide: starts in the mid-two-hundreds a month
- Best price assumes a quarterly plan paid up front — confirm the month-to-month rate before committing
- Medical consult and discreet shipping are included, not add-ons
The medications — and how they're dispensed
The core of the program is compounded GLP-1: semaglutide (the same active ingredient as Ozempic and Wegovy) and tirzepatide (the molecule in Mounjaro and Zepbound). Because these are compounded rather than brand-name, they're mixed by a compounding pharmacy rather than mass-manufactured by Novo Nordisk or Eli Lilly — which is exactly how ReadyRx gets the price down. Beyond weight management, ReadyRx also stocks a small longevity-and-wellness shelf: NAD+, sermorelin, glutathione, a MIC+B12 lipotropic blend, and metformin. If you're someone who likes the idea of getting your GLP-1 and a couple of adjunct therapies from one login, that one-stop range is a genuine convenience.
What genuinely sets ReadyRx apart: it can prove the basics
Plenty of compounders advertise cheap semaglutide. Far fewer can hand you something verifiable. ReadyRx's real differentiator is that its LegitScript certification badge links straight to the LegitScript lookup page, so you can independently confirm the certification yourself instead of taking a logo on faith — and LegitScript is the standard the major ad platforms use to separate legitimate pharmacies from the sketchy ones. On top of that, ReadyRx publishes that every batch is lab-tested for the four QA metrics that actually matter for an injectable: potency, sterility, pH, and endotoxicity. That's the correct list — sterility and endotoxin testing are the difference between a safe shot and a dangerous one. For a sub-two-hundred-dollar compounded program, that level of stated quality control is above average.
The honest gaps you should weigh
Here's where I'd pump the brakes. ReadyRx never names its pharmacies — they're described only as 'FDA-registered compounding pharmacies,' with no specific facility you can look up. The clinicians are called licensed and board-certified, but no individual names or credentials are published, so you can't vet the person signing your prescription. And the widely-quoted '5,000+ members' figure traces back to a directory listing, not an independent audit, so treat it as marketing rather than verified scale. None of these are red flags on their own, but together they mean ReadyRx asks for a bit more trust than a provider that names its pharmacy partner and its medical director outright. That's the main reason we hold our verification confidence here at medium rather than high.
Who should choose it — and who should skip it
Choose ReadyRx if your priority is a low monthly cost for compounded semaglutide or tirzepatide, you're reassured by a certification you can verify yourself, and you're comfortable committing to a quarterly plan to lock in the best rate. The all-50-states coverage and included consult make it an easy on-ramp if you've never done telehealth GLP-1 before.
- Good fit: budget-focused patients who want a verifiable LegitScript certification and stated batch lab testing
- Good fit: people who want GLP-1 plus adjuncts (NAD+, sermorelin, B12) under one roof
- Skip it: anyone who needs to know exactly which pharmacy compounds their medication and which clinician prescribes it
- Skip it: patients who want true month-to-month flexibility without prepaying a quarter
Trust, safety, and medical oversight
On the positive side of the ledger, ReadyRx carries no FDA warning letters on file, holds an independently verifiable LegitScript certification, and discloses a sensible injectable-QA testing panel. That's a stronger trust foundation than many low-cost compounders bring. The weak spot is transparency of the people and pharmacies behind the brand — the unnamed clinicians and unnamed pharmacy partners are the open questions. If you want to understand how we weigh these factors, see our scoring methodology. Our take: this is a legitimately certified operation that simply hasn't published the last mile of detail that would push it into top-tier confidence.
Bottom line
ReadyRx is a credible, genuinely affordable way to get compounded GLP-1, and it earns points most cut-price rivals don't by making its certification independently checkable and stating real lab-testing metrics. Go in clear-eyed on two things: the best price assumes a quarterly prepay, and the company keeps its pharmacy and clinician identities under wraps. If those trade-offs sit fine with you, the value here is real. If you need to know exactly who is compounding and prescribing your medication, you'll want a provider that names names.
Worth pricing against Sunlight ($159/month) and Bodybuilding Health+ ($179/month) before you commit — both sit close to ReadyRx on cost and formulation.
Ready to start with ReadyRx?
Starting at $179/month. See current pricing and start your free consultation.
ReadyRx might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Alternatives to ReadyRx
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this ReadyRx review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with ReadyRx?
Starting at $179/month. See current pricing and start your free consultation.